Ocular Hypotension and Epiretinal Membrane as Risk Factors for Visual Deterioration Following Glaucoma Filtering Surgery.
Journal
Journal of glaucoma
ISSN: 1536-481X
Titre abrégé: J Glaucoma
Pays: United States
ID NLM: 9300903
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
received:
31
08
2020
accepted:
31
01
2021
entrez:
1
6
2021
pubmed:
2
6
2021
medline:
28
9
2021
Statut:
ppublish
Résumé
Postsurgical hypotension at 1 week and the presence of an epiretinal membrane (ERM) were significant risk factors for the deterioration of postsurgical visual acuity (VA) at 3 and 12 months, respectively. The purpose of this study was to assess the effects of an ERM and postsurgical hypotension <6 mm Hg at 1 week on postsurgical VA loss. A total of 69 patients (69 eyes) who underwent trabeculectomy with adjunctive mitomycin C between 2017 and 2019 (mean follow-up period: 22.8 mo) were enrolled, and 14 parameters that could be associated with the deterioration of VA at 3 and 12 months were studied. There was a significant association between VA loss at 3 months and postsurgical intraocular pressure at 1 week (P=0.006 by multiple regression) and hypotony maculopathy (P=0.024 by Fisher exact test). However, this association was lost at 12 months. Instead of postsurgical hypotension, the presence of an ERM was significantly associated with VA loss at 12 months (P=0.035 by Fisher exact test, and P=0.023 by logistic regression). Postsurgical hypotension at 1 week was significantly associated with mid-term, but not long-term, postsurgical VA loss. The presence of an ERM, which was not a risk factor for mid-term acuity loss, was a significant risk factor for VA loss at 12 months.
Identifiants
pubmed: 34060509
doi: 10.1097/IJG.0000000000001832
pii: 00061198-202106000-00010
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
515-525Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure: The authors declare no conflict of interest.
Références
Bindlish R, Condon GP, Schlosser JD, et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology. 2002;109:1336–1341; discussion 1341.
Gedde SJ, Feuer WJ, Lim KS, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology. 2020;127:333–345.
Kashiwagi K, Kogure S, Mabuchi F, et al. Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. Acta Ophthalmol. 2016;94:e561–e570.
Wang Q, Thau A, Levin AV, et al. Ocular hypotony: a comprehensive review. Surv Ophthalmol. 2019;64:619–638.
Fannin LA, Schiffman JC, Budenz DL. Risk factors for hypotony maculopathy. Ophthalmology. 2003;110:1185–1191.
Costa VP, Arcieri ES. Hypotony maculopathy. Acta Ophthalmol Scand. 2007;85:586–597.
Schwenn O, Kersten I, Dick HB, et al. Effects of early post filtration ocular hypotony on visual acuity, long-term intraocular pressure control, and posterior segment morphology. J Glaucoma. 2001;10:85–88.
Gass JDM Bellows JG. Contemporary ophthalmology. Honoring Sir Stuart Duke-Elder. Baltimore, MD: Williams & Wilkins; 1972:343–366.
Lima VC, Prata TS, Castro DPE, et al. Macular changes detected by Fourier-domain optical coherence tomography in patients with hypotony without clinical maculopathy. Acta Ophthalmol. 2011;89:e274–e277.
Dimitrova G, Chihara E, Takahashi H, et al. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58:190–196.
Chihara E, Dimitrova G, Amano H, et al. Discriminatory power of superficial vessel density and prelaminar vascular flow index in eyes with glaucoma and ocular hypertension and normal eyes. Invest Ophthalmol Vis Sci. 2017;58:690–697.
Govetto A, Bhavsar KV, Virgili G, et al. Tractional abnormalities of the central foveal bouquet in epiretinal membranes: clinical spectrum and pathophysiological perspectives. Am J Ophthalmol. 2017;184:167–180.
Yun S, Chua B, Clement CI. Does chronic hypotony following trabeculectomy represent treatment failure? J Curr Glaucoma Pract. 2015;9:12–15.
Chen KC, Jung JJ, Curcio CA, et al. Intraretinal hyperreflective foci in acquired vitelliform lesions of the macula: clinical and histologic study. Am J Ophthalmol. 2016;164:89–98.
Romano MR, Cennamo G, Amoroso F, et al. Intraretinal changes in the presence of epiretinal traction. Graefes Arch Clin Exp Ophthalmol. 2017;255:31–38.
McCarty DJ, Mukesh BN, Chikani V, et al. Prevalence and associations of epiretinal membranes in the visual impairment project. Am J Ophthalmol. 2005;140:288–294.
Vieira L, Cabugueira A, Borges B, et al. Secondary epiretinal membrane after trabeculectomy. J Glaucoma. 2016;25:e576–e580.
Rouvas A, Chatziralli I, Androu A, et al. Long-term anatomical and functional results in patients undergoing observation for idiopathic nontractional epiretinal membrane. Eur J Ophthalmol. 2016;26:273–278.
Tsuchiya S, Higashide T, Sugiyama K. Visual field changes after vitrectomy with internal limiting membrane peeling for epiretinal membrane or macular hole in glaucomatous eyes. PLoS One. 2017;12:e0177526.
Stevenson W, Prospero Ponce CM, Agarwal DR, et al. Epiretinal membrane: optical coherence tomography-based diagnosis and classification. Clin Ophthalmol. 2016;10:527–534.